Pediatric Takayasu Arteritis Workup

  • Author: Christine Hom, MD; Chief Editor: Lawrence K Jung, MD   more...
 
Updated: Dec 6, 2011
 

Approach Considerations

Takayasu arteritis (Takayasu arteritis) has no specific markers. However, the following results can be found in laboratory studies:

  • Complete blood count (CBC) reveals a normochromic, normocytic anemia in 50% of patients with Takayasu arteritis; acute phase reactants are elevated, with leukocytosis and thrombocytosis
  • Westergren erythrocyte sedimentation rate is elevated
  • Comprehensive metabolic profile may indicate elevated transaminases and hypoalbuminemia
  • The von Willebrand factor–related antigen (factor VIII–related antigen) may be elevated
  • Antiendothelial antibodies are present
  • Antinuclear antibody results are usually negative
  • Rheumatoid factor is elevated in 15% of individuals with Takayasu arteritis
  • Increased levels of immunoglobulins G, M, and A are present

Patients with ischemia in all 4 extremities may have falsely low peripheral blood pressures. Accurate blood pressure monitoring in such patients can be obtained reliably only by central systemic measurements.

Next

Arteriography

Arteriography is the criterion standard for assistance in the diagnosis of Takayasu arteritis. It is performed either with invasive angiography or with MRA. (The use of MRA is rapidly increasing.)

Peripheral blood pressure monitoring is frequently inaccurate in persons with Takayasu arteritis; pressure readings during angiography alone may reveal aortic root hypertension.

Arteriography often demonstrates long, smooth, tapered narrowings or occlusions. Some authors recommend arteriography of the entire aorta.

Stenoses occur in 90-100% of patients with Takayasu arteritis, and aneurysm formation in only 27%. Three-dimensional MRA imaging of the aorta and its branches are providing exciting new data that may improve the understanding of the disease. Drawbacks to arteriography, including morbidity from the use of contrast dye in patients with renal disease and cumulative radiation exposure over time, can be avoided by using MRA.

Previous
Next

CT Scanning and MRI

CT scanning and magnetic resonance imaging (MRI) are useful for serial examinations and diagnosis in the early phase of Takayasu arteritis. They may reveal mural thickening of the aorta and luminal narrowing.[9, 10] (See the images below.)

MRI of thorax of 15-year-old adolescent girl with MRI of thorax of 15-year-old adolescent girl with Takayasu arteritis. Note aneurysms of descending aorta. Coronal MRI of abdomen of 15-year-old adolescent gCoronal MRI of abdomen of 15-year-old adolescent girl with Takayasu arteritis. Note thickening and tortuosity of abdominal aorta proximal to kidneys.

Use of contrast may reveal inflammatory lesions prior to the development of stenoses; these lesions may be missed by angiography. Aortic lesions, including stenosis, dilatation, wall thickening, and mural thrombi, are well visualized on MRI, which is less adequate in visualizing distal lesions of the subclavian vessels and common carotids. (See the images below.)

Gadolinium-enhanced cardiovascular MRI has also been used to demonstrate myocardial perfusion defects, which may be important in long-term prognosis.

Noncontrast, T2-weighted, short inversion imaging recovery (STIR) images may be used to monitor edema in the aortic wall, which may be a surrogate for inflammation; edema was found in 94% of patients with clinically active disease.

Large vessel edema was found in 56% of patients in clinical remission, similar to the 42-44% of patients in clinical remission who were found to have active vasculitis on pathology from bypass specimens. The prognostic significance of vessel edema is uncertain, as progression of lesions occurs in areas without edema, and progression may be absent from areas with edema on subsequent studies.

Previous
Next

Additional Imaging Studies

Additional imaging studies include the following[11, 12] :

  • Gallium-67 radionuclide scan - This scan may demonstrate increased uptake in the aorta and branches
  • High-resolution ultrasonography - Duplex Doppler may be used to evaluate and monitor disease in the common carotids and subclavian arteries, with carotid evaluation revealing a homogenous, circumferential thickening of the vessel wall that is distinguishable from atherosclerotic thickening; this imaging study is not useful in evaluating the aorta
  • Chest radiography - Chest radiography may reveal widening of the ascending aorta, an irregular descending aorta, aortic calcifications, and rib notching (late findings)
  • Echocardiography - Perform echocardiography at baseline to evaluate the aortic valve; Perform follow-up echocardiography as indicated to monitor aortic insufficiency
Previous
Next

Histologic Findings

Mononuclear infiltration of the adventitia with perivascular cuffing of the vasa vasorum occurs early in the disease.

Granulomatous changes may be observed in the tunica media with Langerhans cells and central necrosis of elastic fibers and smooth muscle cells. Later, fibrosis of the media and acellular thickening of the intima may compromise the vessel lumen. Grossly, wrinkling of the intima is found.

Histologic specimens seldom are available, due to the large vessels affected, with the exception of specimens obtained during autopsy and bypass surgery.

Previous
 
 
Contributor Information and Disclosures
Author

Christine Hom, MD  Assistant Professor, Department of Pediatrics, Division of Pediatric Rheumatology, New York Medical College

Christine Hom, MD is a member of the following medical societies: American College of Rheumatology, American Medical Association, and Arthritis Foundation

Disclosure: Nothing to disclose.

Chief Editor

Lawrence K Jung, MD  Chief, Division of Pediatric Rheumatology, Children's National Medical Center

Lawrence K Jung, MD is a member of the following medical societies: American Association for the Advancement of Science, American Association of Immunologists, American College of Rheumatology, Clinical Immunology Society, and New York Academy of Sciences

Disclosure: Nothing to disclose.

Additional Contributors

Thomas JA Lehman, MD, FAAP, FACR Clinical Professor of Pediatrics, Department of Pediatrics, Division of Pediatric Rheumatology, Weill-Cornell University; Chief, Hospital for Special Surgery

Thomas JA Lehman, MD, FAAP, FACR is a member of the following medical societies: PM American Allergy Society

Disclosure: Nothing to disclose.

Mary L Windle, PharmD, Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

References
  1. de Pablo P, Garcia-Torres R, Uribe N, et al. Kidney involvement in Takayasu arteritis. Clin Exp Rheumatol. Jan-Feb 2007;25(1 Suppl 44):S10-4. [Medline].

  2. Ozen S, Ruperto N, Dillon MJ, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis. Jul 2006;65(7):936-41. [Medline].

  3. Mwipatayi BP, Jeffery PC, Beningfield SJ, et al. Takayasu arteritis: clinical features and management: report of 272 cases. ANZ J Surg. Mar 2005;75(3):110-7. [Medline].

  4. Hoyer BF, Mumtaz IM, Loddenkemper K, et al. Takayasu arteritis is characterised by disturbances of B cell homeostasis and responds to B cell depletion therapy with rituximab. Ann Rheum Dis. Jan 2012;71(1):75-9. [Medline].

  5. Gedalia A, Cuchacovich R. Systemic vasculitis in childhood. Curr Rheumatol Rep. Dec 2009;11(6):402-9. [Medline].

  6. Maksimowicz-McKinnon K, Clark TM, Hoffman GS. Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients. Arthritis Rheum. Mar 2007;56(3):1000-9. [Medline].

  7. Miller JH, Gunarta H, Stanley P. Gallium scintigraphic demonstration of arteritis in Takayasu disease. Clin Nucl Med. Nov 1996;21(11):882-3. [Medline].

  8. [Guideline] Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation. Feb 8 2005;111(5):697-716. [Medline].

  9. Chung JW, Kim HC, Choi YH, Kim SJ, Lee W, Park JH. Patterns of aortic involvement in Takayasu arteritis and its clinical implications: evaluation with spiral computed tomography angiography. J Vasc Surg. May 2007;45(5):906-14. [Medline].

  10. Kissin EY, Merkel PA. Diagnostic imaging in Takayasu arteritis. Curr Opin Rheumatol. Jan 2004;16(1):31-7. [Medline].

  11. de Leeuw K, Bijl M, Jager PL. Additional value of positron emission tomography in diagnosis and follow-up of patients with large vessel vasculitides. Clin Exp Rheumatol. 2004;22(6 Suppl 36):S21-6. [Medline].

  12. Schmidt WA, Blockmans D. Use of ultrasonography and positron emission tomography in the diagnosis and assessment of large-vessel vasculitis. Curr Opin Rheumatol. Jan 2005;17(1):9-15. [Medline].

  13. Ozen S, Duzova A, Bakkaloglu A, et al. Takayasu arteritis in children: preliminary experience with cyclophosphamide induction and corticosteroids followed by methotrexate. J Pediatr. Jan 2007;150(1):72-6. [Medline].

  14. Daina E, Schieppati A, Remuzzi G. Mycophenolate mofetil for the treatment of Takayasu arteritis: report of three cases. Ann Intern Med. Mar 2 1999;130(5):422-6. [Medline].

  15. Shinjo SK, Pereira RM, Tizziani VA, Radu AS, Levy-Neto M. Mycophenolate mofetil reduces disease activity and steroid dosage in Takayasu arteritis. Clin Rheumatol. Nov 2007;26(11):1871-5. [Medline].

  16. Buonuomo PS, Bracaglia C, Campana A, et al. Infliximab therapy in pediatric Takayasu's arteritis: report of two cases. Rheumatol Int. Oct 23 2009;[Medline].

  17. Hoffman GS, Merkel PA, Brasington RD, Lenschow DJ, Liang P. Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. Arthritis Rheum. Jul 2004;50(7):2296-304. [Medline].

  18. Karageorgaki ZT, Mavragani CP, Papathanasiou MA, Skopouli FN. Infliximab in Takayasu arteritis: a safe alternative?. Clin Rheumatol. Jun 2007;26(6):984-7. [Medline].

  19. Tanaka F, Kawakami A, Iwanaga N, et al. Infliximab is effective for Takayasu arteritis refractory to glucocorticoid and methotrexate. Intern Med. 2006;45(5):313-6. [Medline].

  20. Seitz M, Reichenbach S, Bonel HM, Adler S, Wermelinger F, Villiger PM. Rapid induction of remission in large vessel vasculitis by IL-6 blockade. A case series. Swiss Med Wkly. Jan 17 2011;141:w13156. [Medline].

  21. Haberhauer G, Kittl EM, Dunky A, Feyertag J, Bauer K. Beneficial effects of leflunomide in glucocorticoid- and methotrexate-resistant Takayasu's arteritis. Clin Exp Rheumatol. Jul-Aug 2001;19(4):477-8. [Medline].

Previous
Next
 
Aortogram of a 15-year-old adolescent girl with Takayasu arteritis. Note large aneurysms of descending aorta and dilatation of innominate artery.
MRI of thorax of 15-year-old adolescent girl with Takayasu arteritis. Note aneurysms of descending aorta.
Coronal MRI of abdomen of 15-year-old adolescent girl with Takayasu arteritis. Note thickening and tortuosity of abdominal aorta proximal to kidneys.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.